GSE196067
ZNF117 target ChIP-seq
Glioblastoma (GBM) is a deadly disease without effective treatment. Because glioblastoma stem cells (GSCs) contribute to tumor resistance and recurrence, improved treatment of GBM can be achieved by eliminating GSCs through inducing their differentiation. Prior efforts have been focused on studying GSC differentiation towards the astroglial lineage. Overall design: GS5 cells were used for ZNF117 ChIP using anti-ZNF117 antibody